Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Thursday - Acuity ( NYSE:AYI ) , Apple ( NASDAQ:AAPL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Stanley raised Acuity Inc. ( NYSE:AYI ) price target from $365 to $425.
GO vs. CL: Which Stock Is the Better Value Option?
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Grocery Outlet Holding Corp. ( GO Quick QuoteGO - ) and Colgate-Palmolive ( CL Quick QuoteCL - ) . But which of these two stocks offers value investors a better bang for their buck right now?
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend King Down 26% to Buy Right Now
This Dividend King is available to investors at a once-in-a-decade valuation.
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
CL powers growth with pricing strength, cost savings, premium innovation and AI-driven supply-chain agility.
Here's Why Colgate-Palmolive ( CL ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Ridiculously Cheap Dividend Stocks Passive Income Investors Can Buy Now in 2025!
Dividend stocks become more attractive as interest rates decrease.
Colgate Agrees To Show Safe Toothpaste Amounts For Kids After Legal Pressure - Colgate-Palmolive ( NYSE:CL )
Colgate will depict pea-sized toothpaste amounts in ads and packaging for kids under six by November 1. Paxton has also launched a similar probe into Crest's advertising practices. Up Next: Wall Street trader's 34-0 strategy goes public this week. See it first →
Can Colgate's New Productivity Program Drive Long-Term Growth?
Colgate launches a $300-$400M productivity program to boost efficiency, cut costs and fuel long-term growth amid market pressures.
Kyndryl and VML Form Global Partnership to Unlock the Future of Customer Experience - Kyndryl Hldgs ( NYSE:KD ) , WPP ( NYSE:WPP )
First-of-a-kind collaboration enables brands to design personalized customer experiences informed by data and AI, powered by modern infrastructure
Dalfen Industrial Acquires Class A Logistics Facility in Atlanta
DALLAS, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Dalfen Industrial has announced the off-market acquisition of a 350,000-square-foot, Class A industrial facility located at 4975 Powder Springs Dallas Road in Powder Springs, Georgia-one of Atlanta's premier logistics submarkets.
Procter & Gamble vs. Colgate: Which Household Staple Is a Better Pick?
PG's vast scale and CL's focused specialization showcase two distinct strategies shaping the evolving landscape of global consumer staples.
3 Standout Themes That Emerged From Earnings Season
Tariffs are beginning to take a toll, but can the economy hold up?
Procter & Gamble's Innovation Playbook: Working or Wearing Thin?
PG leans on bold product launches like Tide evo and Swiffer PowerMop, but questions remain on whether innovation can keep fueling growth.
3 Spectacular Stocks You Can Buy Now and Hold Forever
The ultimate long-term investing strategy is buying stocks and holding them forever.
Will Slowing Global Demand Dent PG's Emerging Market Strategy?
Procter & Gamble's emerging market strength in Latin America and India shows resilience despite global demand concerns.
Why Colgate-Palmolive ( CL ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Colgate's Innovation Drive Market Share Gains in 2025?
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
Brandon Hall Group™ Announces 2025 HCM Excellence Awards® Winners in Live Broadcast
Boca Raton, FL, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Brandon Hall Group™, the leading HCM research and analyst firm, today announced the winners of its 2025 HCM Excellence Awards® during a special live broadcast.
PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
Procter & Gamble faces slowing category growth as inflation and tariffs challenge its long-running price hike strategy.
The CFO's Balancing Act: Value Creation in an Era of Volatility
From Colgate-Palmolive to Thomas Cook, finance leaders share how they're redefining trust, agility, and stakeholder engagement for long-term relevance.
ADRNY vs. CL: Which Stock Is the Better Value Option?
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Ahold NV ( ADRNY Quick QuoteADRNY - ) and Colgate-Palmolive ( CL Quick QuoteCL - ) . But which of these two stocks offers value investors a better bang for their buck right now?
Procter & Gamble's Margins Stay Firm: Is Premiumization Paying Off?
PG expands core margins and grows EPS despite volatility, signaling the strength of its premiumization strategy.
Top 3 Risk Off Stocks That May Rocket Higher This Quarter - Mondelez International ( NASDAQ:MDLZ ) , Colgate-Palmolive ( NYSE:CL )
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Recent Filing Shows That Sen. Shelley M Capito Bought Over $17K Worth of American Express Stock - American Express ( NYSE:AXP ) , Colgate-Palmolive ( NYSE:CL )
A August filing shows that Senator Shelley M Capito reported a purchase in American Express AXP, valued between $17,003 and $80,000. The transaction date is listed as July 1, 2025, with the report published on August 4, 2025. At present, American Express shares are trading up 0.46% at $299.96.
These Analysts Lower Their Forecasts On Colgate-Palmolive After Q2 Results - Colgate-Palmolive ( NYSE:CL )
Colgate-Palmolive Company CL posted better-than-expected second-quarter earnings on Friday. Colgate-Palmolive reported second-quarter adjusted earnings per share of 92 cents, beating the analyst consensus estimate of 89 cents. Quarterly sales of $5.11 billion ( +1% year over year ) outpaced the ...
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday? - Apple ( NASDAQ:AAPL )
It's a rough start to the new month for Wall Street, as major U.S. stock indices plunged by midday Friday, setting the stage for a negative weekly close. SPY ETF is breaking past support. Check the chart here.
Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View
CL beats Q2 earnings and sales estimates on pricing and organic growth but narrows the full-year organic sales view to the low end of the 2-4% range.
Nonfarm Payrolls Come in SIgnificantly Below Expectations
The all-important Employment Situation report for July - nonfarm payrolls and unemployment - is out this morning, and results are far below projections: +73K new jobs were filled last month, lower than the +100K expected. The Unemployment Rate ticked up 10 basis points ( bps ) to 4.2%, which is ...
Jobs Shrink in the Summer of '25, Pre-Markets Lower
+73K new jobs were filled last month, lower than the +100K expected. The Unemployment Rate ticked up 10 bps.
Why Is Colgate-Palmolive Stock Falling Friday? - Colgate-Palmolive ( NYSE:CL )
Colgate reported Q2 EPS of $0.92 vs. $0.89 estimate, with sales rising 1% to $5.11B, beating Street expectations. Company announced a 3-year productivity plan with up to $300M in charges to streamline operations and support 2030 goals.
Colgate-Palmolive ( CL ) Q2 Earnings and Revenues Beat Estimates
Colgate-Palmolive (CL) delivered earnings and revenue surprises of +3.37% and +1.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Price Over Earnings Overview: Colgate-Palmolive - Colgate-Palmolive ( NYSE:CL )
In the current session, Colgate-Palmolive Inc. CL is trading at $85.35, after a 0.52% drop. Over the past month, the stock decreased by 9.06%, and in the past year, by 17.94%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
These stocks are not only cheap, but they also yield between 2.4% and 5.6%.
Colgate Q2 Earnings: Do Productivity Initiatives Suggest a Beat?
CL's Q2 results are likely to reflect benefits from pricing, innovation and gross margin gains amid inflation and foreign exchange headwinds.
Countdown to Colgate-Palmolive ( CL ) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Colgate-Palmolive (CL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analysts Estimate Colgate-Palmolive ( CL ) to Report a Decline in Earnings: What to Look Out for
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Colgate-Palmolive ( CL ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Unlocking Growth in the Consumer Packaged Goods Market: What's Driving the 2030 Surge
Delray Beach, FL, July 23, 2025 ( GLOBE NEWSWIRE ) -- According to MarketsandMarkets™, the consumer packaged goods ( CPG ) market size is on a steady growth path, projected to rise from USD 3,450.12 billion in 2025 to USD 4,235.01 billion by 2030, growing at a CAGR of 4.2 percent.
Albertsons' Q1 Earnings Beat Estimates, Identical Sales Rise 2.8% Y/Y
ACI Q1 identical sales climb 2.8% on pharmacy and digital growth, though margins and EPS decline.
Zacks Industry Outlook Highlights Procter & Gamble, Colgate-Palmolive, Church & Dwight and Grocery Outlet
PG, CL, CHD, and GO push through margin pressures with innovation, cost control, and digital growth amid tough consumer headwinds.
Can Clorox's Pricing Strength Keep Earnings Buoyant in 2025?
CLX leverages targeted pricing, cost cuts and premiumization to boost margins despite soft volume trends.
5 High-ROE Stocks to Buy as Markets Soar Despite Tariff Threats
DIS, TEL, FTNT, BBVA and CL are some of the stocks with high ROE to profit from as markets rise despite a fresh tariff salvo.
4 Resilient Consumer Product Stocks to Watch Amid Market Challenges
Despite rising costs and changing consumer trends, PG, CL, CHD and GO remain resilient, leveraging strategic measures to sustain growth.
4 Low-Beta Defensive Stocks to Buy as Rate Cut Uncertainty Continues
CL, KO, ATO, and FTS stand out as low-beta, high-dividend plays amid Fed rate cut delays and rising market volatility.
Can Colgate's Pricing Strength Keep Earnings Buoyant in 2025?
CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Trump's deportations are hurting Constellation Brands' beer sales
The brewer, which owns Modelo, Corona and Pacifico, says that roughly half of its beer sales come from Latinos in the U.S.
PetVivo Reports Fiscal 2025 Results
MINNEAPOLIS, MN, US, June 30, 2025 ( GLOBE NEWSWIRE ) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. ( OTCQB: PETV. OTCPINK: PETVW ) , a leading biomedical company delivering innovative medical therapeutics for equines and companion animals, reported results ...
